Nothing goes into a strategy without sector/ security team approval; the macro team sets top-down themes ... The team has actually expanded, counting 20 analysts, several of whom have been ...
Shares in the Boston-based biotech creator, which had a standout success in forming Karuna Therapeutics, trade around cash levels — a "huge value disconnect" its leaders are trying to bridge.
The proposals Trump discussed at economic clubs in Detroit and Chicago make no sense macroeconomically and would cause unethical microeconomic results.